If you watch or run in a marathon, which covers 26 miles (42 km), you may see some runners holding signs that have a finishing time posted on them.  For example, the signs may say ‘2:30,’ ‘3:00,’ or ‘5:00.’ There may be a sign for every 15 minutes of completion time. 

The runners holding these signs are on track to finish in the time displayed on the sign. They are known as ‘pace bunnies.’  Sometimes they even wear rabbit …

“So, how much time are they giving you?” an old friend from college asked me with great concern in his voice.

We had lost touch for several years, and he had only recently learned of my ongoing battle with multiple myeloma.

Ah, the classic ‘how much time?’ question.

I replied. “My doctors have assured me, with a great deal of certainty, that I will have no more than (dramatic pause)... no more than twenty-four hours a day to live my …

Results from a Phase 1 study indicate that tabalumab in combination with Velcade demonstrates both efficacy and safety in myeloma patients who have relapsed after several previous therapies.

Dr. Nooper Raje from Massachusetts General Hospital in Boston presented the results of the study at the American Society of Hematology (ASH) annual meeting earlier this month. She explained that tabalumab was very promising in this particular patient population, and added that “this was a very well tolerated regimen.”

However, Dr. Raje …

The end of the year provides a great time for review and reflection.

2012 has been a momentous one for me in my journey with myeloma. It included both difficult and awe-inspiring moments.

I went off chemotherapy in February in preparation for a stem cell transplant. I have not been back on it since then. No more exciting steroid “highs” - but no more steroid rages either!

In early March, I underwent a stem cell transplant. I lost …

In the western world where I live, the long dark nights of December bring the light and festivities of the close of our calendar year. People honor and celebrate in many ways and meanings. It is as if we are all aboard a train that is traveling through this territory, whether we like it or not.

Despite the particular problems facing the nation or the world - and despite our personal faith or lack of it - a call for …

As the 2012 holiday season reaches it peak, all of us here at The Myeloma Beacon would like to thank you, our readers, for giving us the greatest gift possible: your time.  We appreciate your coming to The Beacon and reading our articles, sharing your thoughts about them with us, and discussing them – and many other topics! – in our forums.

The holiday season is a time of many different traditions.  It also is a busy time, when it …

This year’s meeting of the American Society of He­ma­tol­ogy (ASH) was held De­cem­ber 8 through 11 in Atlanta.

During the meeting, The Beacon pub­lished daily up­dates that provided overviews of the im­por­tant mul­ti­ple myeloma findings pre­sented during the meeting.  After the meeting concluded, The Beacon began pub­lishing in-depth articles about the key re­search findings.

This article, how­ever, shifts the focus to the bigger picture: What were the key findings of the meeting? Were there re­­sults …